Success Stories: Botulinum Toxin Treatment Program

This program has been in operation for over 10 years. More than 600 patients have been treated and over 1000 treatments have been given. No serious side effects have been reported. Many patients have benefited from the interventions.

Bradley L. Schlaggar, M.D., Ph.D., Named President and CEO of Kennedy Krieger Institute

We’re thrilled to welcome Bradley L. Schlaggar, M.D., Ph.D., to the Kennedy Krieger family as our next President and CEO.

Learn more.

Appointments & Referrals



Read inspiring stories, news and updates about the Institute's patient care, research, special education, professional training, and community programs.


Resource Finder


A free resource that provides access to information and support for individuals and families living with developmental disabilities.